Search
The final report of the Commission on Combating Synthetic Opioid Trafficking summarizes the fentanyl crisis and makes recommendations for a coordinated federal response to help save American lives.
Read More
A 16-year-old in Kansas died after he was sold a counterfeit pill containing fentanyl by a drug dealer on Snapchat.
Read More
On February 2nd PSM held a one-hour webinar to discuss advocacy opportunities and federal legislation such as the DRUGS Act, which could make positive change.
Read More
Parents in Mississippi have asked legislators for help after they lost their 19-year-old son to a counterfeit pill sold to him on Snapchat.
Read More
Has your family been affected by fentanyl or fake pills? Learn about opportunities in 2022 to advocate to address the crisis in this webinar about federal legislation this year.
Read More
Esupplementsales, LLC was informed by Amazon that laboratory analysis has found the product to be tainted with tadalafil, an ingredient known as a phosphodiesterase (PDE-5) inhibitor found in an FDA approved product for the treatment of male erectile dysfunction. The presence of tadalafil in Hard Dawn Rise and Shine Capsules renders the product an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Read More
Two nurses in New York allegedly made $1.5 million over a three month period forging vaccine cards and entering them in New York’s statewide vaccine database. Catch up on this and 16 more stories.
Read More
Counterfeit pills made with fentanyl have proliferated across the U.S. since 2015, killing people in all 50 states. The pills have become heavily trafficked, easier to find and more deadly.
This infographic shows how the fentanyl pill trade has changed.
Read More
First among the more that two dozen stories in this week’s round up: Gilead Sciences is suing a a network of unauthorized drug suppliers and distributors for selling over 85,000 bottles of counterfeit HIV medicines sold as legitimate Biktarvy and Descovy to U.S. pharmacies.
Read More
The “Domain Reform for Unlawful Drug Sellers” or “DRUGS” Act would require domain name sellers to lock and suspend websites when regulators or law enforcement show evidence that they are selling drugs illegally.
This would be a game changer for patient safety.